The Top Analysis for Bristol-Myers Squibb Co. (BMY)
The top analysis was written by
Sure Dividend Blog titled
Blue Chip Stocks In Focus: Bristol-Myers Squibb Is Bristol-Myers Squibb Co. (BMY) a buy?
Based on 2 suggestion
s, Bristol-Myers Squibb Co.(BMY) is recommended as a BUY at $61.99.
Are These Ratings Good?
Based on 2 ratings, the average Return is -26.53%.
The community has not been successfully rating this stock.
Forecast for Bristol-Myers Squibb Co. (BMY)
Based on the most recent price of $48.99,
the two year forecast for BMY is $56.09.
The four year forecast is $63.20
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.